Nuwellis Free Cash Flow 2011-2024 | NUWE
Nuwellis free cash flow from 2011 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Nuwellis Annual Free Cash Flow | |
|---|---|
| 2023 | -18.09 |
| 2022 | -15.27 |
| 2021 | -18.06 |
| 2020 | -16.84 |
| 2019 | -16.86 |
| 2018 | -14.76 |
| 2017 | -12.18 |
| 2016 | -16.41 |
| 2015 | -23.19 |
| 2014 | -23.00 |
| 2013 | -17.66 |
| 2012 | -13.24 |
| 2011 | -13.54 |
| 2010 | -7.22 |
| Nuwellis Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | -5.67 |
| 2024-03-31 | -2.89 |
| 2023-12-31 | -18.09 |
| 2023-09-30 | -15.37 |
| 2023-06-30 | -11.42 |
| 2023-03-31 | -6.12 |
| 2022-12-31 | -15.27 |
| 2022-09-30 | -12.13 |
| 2022-06-30 | -8.85 |
| 2022-03-31 | -4.90 |
| 2021-12-31 | -18.06 |
| 2021-09-30 | -13.88 |
| 2021-06-30 | -9.34 |
| 2021-03-31 | -5.44 |
| 2020-12-31 | -16.84 |
| 2020-09-30 | -13.37 |
| 2020-06-30 | -8.83 |
| 2020-03-31 | -5.51 |
| 2019-12-31 | -16.86 |
| 2019-09-30 | -12.80 |
| 2019-06-30 | -9.03 |
| 2019-03-31 | -4.95 |
| 2018-12-31 | -14.76 |
| 2018-09-30 | -12.02 |
| 2018-06-30 | -8.60 |
| 2018-03-31 | -5.09 |
| 2017-12-31 | -12.18 |
| 2017-09-30 | -8.98 |
| 2017-06-30 | -5.72 |
| 2017-03-31 | -1.61 |
| 2016-12-31 | -16.41 |
| 2016-09-30 | -13.67 |
| 2016-06-30 | -9.17 |
| 2016-03-31 | -5.70 |
| 2015-12-31 | -23.19 |
| 2015-09-30 | -18.41 |
| 2015-06-30 | -12.90 |
| 2015-03-31 | -7.16 |
| 2014-12-31 | -23.00 |
| 2014-09-30 | -17.56 |
| 2014-06-30 | -12.04 |
| 2014-03-31 | -6.73 |
| 2013-12-31 | -17.66 |
| 2013-09-30 | -11.84 |
| 2013-06-30 | -7.59 |
| 2013-03-31 | -4.12 |
| 2012-12-31 | -13.24 |
| 2012-09-30 | -9.80 |
| 2012-06-30 | -6.92 |
| 2012-03-31 | -4.86 |
| 2011-12-31 | -13.53 |
| 2011-09-30 | -9.69 |
| 2011-06-30 | -6.26 |
| 2011-03-31 | -2.81 |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.004B | $0.009B |
| Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $206.837B | 25.23 |
| Intuitive Surgical (ISRG) | United States | $191.293B | 100.01 |
| Alcon (ALC) | Switzerland | $42.858B | 28.68 |
| Edwards Lifesciences (EW) | United States | $38.815B | 24.65 |
| IQVIA Holdings (IQV) | United States | $38.763B | 21.36 |
| IDEXX Laboratories (IDXX) | United States | $34.892B | 41.09 |
| DexCom (DXCM) | United States | $29.037B | 43.73 |
| Waters (WAT) | United States | $22.907B | 33.87 |
| STERIS (STE) | Ireland | $21.985B | 25.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.643B | 0.00 |
| Hologic (HOLX) | United States | $18.526B | 19.55 |
| Sysmex ADR (SSMXY) | Japan | $12.594B | 39.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.447B | 12.78 |
| Globus Medical (GMED) | United States | $11.296B | 28.77 |
| Teleflex (TFX) | United States | $9.083B | 14.49 |
| Penumbra (PEN) | United States | $9.066B | 88.81 |
| Masimo (MASI) | United States | $8.612B | 41.67 |
| Glaukos (GKOS) | United States | $7.919B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.986B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.592B | 26.02 |
| TransMedics (TMDX) | United States | $3.068B | 97.25 |
| Inari Medical (NARI) | United States | $3.003B | 0.00 |
| Veracyte (VCYT) | United States | $2.964B | 88.93 |
| LivaNova (LIVN) | United Kingdom | $2.878B | 16.61 |
| Nihon Kohden (NHNKY) | Japan | $2.557B | 19.42 |
| Elekta AB (EKTAY) | Sweden | $2.252B | 18.35 |
| Tandem Diabetes Care (TNDM) | United States | $2.043B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.914B | 10.00 |
| RxSight (RXST) | United States | $1.832B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.316B | 0.00 |
| Artivion (AORT) | United States | $1.162B | 77.03 |
| OPKO Health (OPK) | United States | $1.099B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.091B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.915B | 15.55 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.722B | 39.01 |
| SiBone (SIBN) | United States | $0.652B | 0.00 |
| Paragon 28 (FNA) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.610B | 14.39 |
| Pacific Biosciences Of California (PACB) | United States | $0.601B | 0.00 |
| AxoGen (AXGN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.383B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.383B | 25.71 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.45 |
| Delcath Systems (DCTH) | United States | $0.310B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.215B | 0.00 |
| NeuroPace (NPCE) | United States | $0.208B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.157B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.117B | 17.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| 908 Devices (MASS) | United States | $0.101B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Neuronetics (STIM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |